Latest News and Press Releases
Want to stay updated on the latest news?
-
Company announcement no. 21 / 2025Schindellegi, Switzerland – 15 April 2025 Shareholders approve all resolutions at the Annual General Meeting 2025 The shareholders of Trifork Group AG (“Trifork“)...
-
Press release Trifork secures landmark project to transform Oman’s healthcare system Muscat, 11 April 2025 – The Ministry of Health in Oman has selected Trifork to develop a state-of-the-art Revenue...
-
Park Street A/S – Annual Report 2024 Copenhagen, 4 April 2025 Park Street result analysis primarily uses the term EBVAT (Earnings before value adjustments and tax) to measure the Group’s operating...
-
Park Street A/S – Annual Report 2024 Copenhagen, 4 April 2025 Park Street result analysis primarily uses the term EBVAT (Earnings before value adjustments and tax) to measure the Group’s operating...
-
COPENHAGEN, Denmark, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Copenhagen Infrastructure Partners, through its Energy Transition Fund I (CI ETF I), in partnership with Vestforbrænding, Denmark’s largest...
-
Novel paradigm for therapeutics based on RNA splicing modulationLead program in Huntington’s disease Denmark – Odense – 07/01/2025 – Inverna Therapeutics, a novel Danish biotech company at the...
-
LOS ANGELES, Dec. 11, 2024 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a Los Angeles-based bioelectronics company, announced today that the Center for Evidence-Based Psychiatry (CEBP) in Denmark has...
-
Press Release Trifork and Swiss Post forge partnership to advance digital transformation of healthcare infrastructure in Switzerland Zürich, Switzerland, November 25, 2024 – Trifork has partnered...
-
NMD Pharma adds new capabilities with several senior recruits to support its growing business and pipeline Aarhus, Denmark, 11 July 2024 – NMD Pharma A/S, a clinical-stage biotech company dedicated...
-
NMD Pharma adds new capabilities with several senior recruits to support its growing business and pipeline Aarhus, Denmark, 11 July 2024 – NMD Pharma A/S, a clinical-stage biotech company dedicated...